A One Step Strategy Based on Hollow Gold Nanoparticles to Detect C-Reactive Protein with High Sensitivity (Hs-CRP) in Serum for Monitoring Cardiovascular Disease
Changyou Luo,Ruiqing Zhang,Ji Liu,Xingyue He,Shengzhou Li,Chuanjiang Ran,Songbo Ma,Yan Shen
DOI: https://doi.org/10.2147/ijn.s436391
IF: 7.033
2024-01-26
International Journal of Nanomedicine
Abstract:Changyou Luo, 1, &ast Ruiqing Zhang, 2, &ast Ji Liu, 1, &ast Xingyue He, 1 Shengzhou Li, 1 Chuanjiang Ran, 1 Songbo Ma, 3 Yan Shen 1 1 Department of Pharmaceutics, China Pharmaceutical University, Nanjing, 211100, People's Republic of China; 2 Children's Hospital of Nanjing Medical University, Nanjing, People's Republic of China; 3 Department of Oral and Maxillofacial Surgery, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, Jiangsu, 225300, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yan Shen; Songbo Ma, Email ; Purpose: Rapid detection and diagnosis of diseases facilitate timely and effective treatment of cardiovascular diseases (CVD). The establishment of a one-step rapid detection method provides a new method for the initial screening and disease risk assessment of patients with cardiovascular diseases in primary medical units. Methods: Hollow gold nanoparticles (HGNPs) were synthesized using a cobalt template method followed by use as signal amplification probes for ultra-sensitive quantitative detection of serum C-reactive protein (CRP). To induce the localized surface plasmon resonance (LSPR) and improve protein labeling efficiency, we developed a sensitive detection mode by coating polyvinylpyrrolidone (PVP-K30) on the HGNPs, resulting in a significant improvement in detection performance. Results: Compared to traditional colloidal GNP-based LFTA, PVP-coated HGNPs exhibit a lower visual detection limit of 1 ng/mL, which a 25-fold decrement compare to using GNPs as the antibody-labeled probe, and the detection limit could be reduced to 0.14 ng/mL under the quantitative instrument. Conclusion: The one-step method based on HGNP immunochromatographic strips modified with PVP established in this study can be used for the detection of CRP and hs-CRP in biological samples. The performance of the immunochromatographic technique designed in this study was evaluated from the perspective of synthetic markers, and the application conditions of this strip were screened, verifying its high specificity, indicating that it has high sensitivity and strong detection limit compared to colloidal gold. The sensitivity of the hollow gold immunochromatographic test strip in this article has been increased by about 25 times, providing a new method for rapid detection of CVD in clinical diagnosis. Keywords: C-reactive protein, lateral flow immunoassay, hollow gold nanoparticles, in vitro diagnostics, polyvinylpyrrolidone Cardiovascular disease (CVD) is one of the leading causes of death in the world. It is a chronic disease that develops gradually over a lifetime. Symptoms usually occur only in advanced disease, and in severe cases, major cardiovascular events such as acute myocardial infarction, stroke and pulmonary embolism occur. The World Health Organization estimates that CVD causes about 30,000 deaths every day. In China, cardiovascular diseases account for the first place in the total death causes of urban and rural residents, accounting for 46.74% in rural areas and 44.26% in urban areas. 1 With the younger age of tobacco use, poor diet and lack of exercise, cardiovascular diseases are becoming more popular in young ages. 2 The economic burden brought by cardiovascular diseases to residents and society is increasing gradually, and it has become a major public health problem. Therefore, early detection, diagnosis, and treatment are important for slowing the progression of cardiovascular disease to advanced stages and improving overall outcomes. Electrocardiograms and cardiac magnetic resonance (CMR) are often the gold standard for diagnosing certain cardiovascular diseases, but the application of these assistive tools are limited by high cost, high requirements for technical expertise, and is not suitable as a screening tool for the general population. 3,4 This brings a lot of difficulties to early diagnosis of CVD and seriously affects the recovery of patients. In order to break through the current bottleneck, emerging technologies such as immunochromatography and microfluidic technology have the advantages of low cost, simple instruments, and easy integration, and have been developed to a relatively mature level. 4 They play an important role in the early prevention, diagnosis, and treatment of cardiovascular diseases. However, considering the application situation, microfluidic technology still has certain limitations. Inflammation is an important player in chronic disease and cardiovascular disease. 5 The presence of chronic low-grade -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology